Sign in
4

Changes in Ownership

ENDONOVO THERAPEUTICS, INC. Filed Acc 0001645470-19-000018

CEO bought 21,000 shares at an average $0.02 ($413)

From the SEC's structured data for this filing

Trades in this filing

Collier Alan Brian · CEO

Table I: Non-derivative

9 lines
Date Transaction Shares Price Value Owned after D/I
2019-03-08 Purchase : show line 1 in the form +2,000 $0.02 $39 21,795,123 D
2019-03-08 Purchase : show line 2 in the form +5,000 $0.02 $105 21,800,123 D
2019-03-11 Purchase : show line 3 in the form +500 $0.02 $10 21,800,623 D
2019-03-11 Purchase : show line 4 in the form +2,000 $0.02 $38 21,802,623 D
2019-03-11 Purchase : show line 5 in the form +500 $0.02 $10 21,803,123 D
2019-03-11 Purchase : show line 6 in the form +2,000 $0.02 $38 21,805,123 D
2019-03-11 Purchase : show line 7 in the form +2,000 $0.02 $38 21,807,123 D
2019-03-11 Purchase : show line 8 in the form +5,000 $0.02 $96 21,812,123 D
2019-03-12 Purchase : show line 9 in the form +2,000 $0.02 $39 21,814,123 D
Open-market purchases · 21,000 sh · avg $0.02 · $413
Loading xslF345X03/primary_doc.xml…